Volodymyr Martynenko

Volodymyr Martynenko

Auto-generated profile, based on publicly available information

Volodymyr Martynenko


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2025 in bioRxiv
Verified
Preprint
Open access
MOMaria Obolenska
Maria Obolenska
OLOlexandr Lykhenko
Olexandr Lykhenko
YKYevhenii Kukuruza
Yevhenii Kukuruza
VMVolodymyr Martynenko
Volodymyr Martynenko
YPYehor Poliakov
Yehor Poliakov
Berthold HuppertzBerthold Huppertz
Berthold Huppertz
During gestation, the human placenta develops as a fetal organ in direct contact with maternal cells and tissues. Most pregnancy complications, such as preeclampsia and fetal growth restriction, have their roots early in pregnancy, most probably in dysregulation of placental development and/or disturbances in the interaction with maternal (immune) cells. Here, we applied an integrative analysis of open-access gene expression data on the human placenta, comparing expression levels between the first and second trimesters of healthy pregnancy, with a focus on differentially expressed genes related to immune processes. The holistic approach of our study revealed differentially expressed genes involved in the recognition and elimination of potential PAMPs and DAMPs, transendothelial cell migration, cytokine production, transplacental IgG transport, and maintenance of immune tolerance during the transition from the first to the second trimester of placental development. Most DEGs show an increased expression. Only a few genes, DEFB1 , SLPI , and LCN2, which encode antimicrobial proteins, homeostatic chemokines, and a pleiotropic PAEP that maintains tolerance, display maximal expression in the first trimester, followed by further down-regulation. The cell types deconvolutions revealed the typical representation of placental cells.